Lumida
/ECL
⌘K
Ecolab Inc

Ecolab Inc

ECL
$276.18USD+1.69%+4.58 today

MARKET CAP

77.4B

P/E (TTM)

37.4x

FWD P/E

DAY RANGE

$273 – $278

52W RANGE

$243
$309

AI Summary

Stalk
Sell NowMedium

ECL remains in a Stage 3 downtrend, with a decisive support failure below the 276–278 zone and follow-through selling. Price is extended below the declining EMAs and 200-day SMA, with neutral overbought/oversold conditions and no clear exhaustion, signaling further downside. Under a Stable strategy, immediate sell-side participation is warranted, ideally on a retest of the broken support near the 276–278 area for rejection-based entries.

  • Q2 2026 adjusted EPS rose 11% to $8.15, driven by 5% organic sales growth.
  • Life sciences revenue grew 15% while Ecolab Digital surged 27%, boosting margins.
  • Rising commodity prices strain margins despite pricing strategies.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$12.7B$14.2B$15.3B$15.7B$16.1B
YoY %+8.0%+11.4%+8.0%+2.7%+2.2%
P / Sales5.3x3.0x3.7x4.3x4.7x
EV / Sales6.4x3.9x4.5x5.1x5.5x
Gross Profit, Adj.$5.1B$5.4B$6.2B$6.8B$7.2B
YoY %+4.8%+4.7%+15.1%+11.0%+4.5%
Margin %40.2%37.8%40.2%43.5%44.5%
EV / Gross Profit15.9x10.4x11.3x11.6x12.5x
EBITDA, Adj.$2.5B$2.6B$2.9B$3.7B$3.7B
YoY %+6.5%+3.8%+10.4%+28.2%-0.6%
Margin %20.0%18.6%19.0%23.7%23.1%
EV / EBITDA32.0x21.1x23.9x21.3x24.0x
EBIT$1.7B$1.7B$2.0B$2.8B$2.7B
YoY %+21.9%+0.1%+17.0%+40.7%-2.3%
Margin %13.4%12.0%13.0%17.8%17.0%
EV / EBIT47.9x32.8x35.0x28.4x32.6x
Net Income$1.1B$1.1B$1.4B$2.1B$2.1B
YoY %+193.8%-3.4%+25.7%+53.9%-1.7%
Net Margin8.9%7.7%9.0%13.4%12.9%
EPS (GAAP)$3.91$3.81$4.79$7.37$7.28
YoY %+194.2%-2.6%+25.7%+53.9%-1.2%